Recombinetics, Inc. (RCI)

Transforming Public Health by Engineering Animals for Biomedicine & Food Production .

  • Stage Product In Development
  • Industry Biotechnology
  • Location St Paul, MN, USA
  • Currency USD
  • Founded August 2008
  • Employees 9
  • Website recombinetics.com

Company Summary

Recombinetics has developed and acquired a portfolio of proprietary genome engineering technologies it uses to make precise modifications to the genomes of several livestock species. The results are animals with enhanced value for biomedicine and agricultural markets. First products are pigs that exhibit human heart disease. Customers are academic scientists, pharmaceutical and medical device companies, and CROs that want a consistent model.

Team

  • Scott Fahrenkrug
    CEO & Chairman

  • Mark Walton
    CMO (Chief Marketing Officer)

  • Perry Hackett
    CSO (Chief Scientific Officer)

  • Justin Zenanko
    CFO

  • Cliff Steer
    CMO (Chief Medical Officer)

Advisors

  • General: Cameron Law Office, Business: Larkin & Hoffman, IP: Dardi & Herbert, LLP
    Lawyer
    Unconfirmed
    Audits: Olsen Thielen, Taxation & General: Deloitte Touche
    Accountant
    Unconfirmed

Previous Investors

  • Founders, Friends and Family
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free